• Whitley i2 Instrument Workstation

    This workstation can be used as a stand-alone unit or connected to a Whitley Hypoxystation via the new Whitley Transfer Tunnel, prepare cell lines under hypoxic conditions and then transfer directly into the i2 without exposure to air. Read More
  • Hypoxic Workstations

    HypOxystation® brand hypoxia workstations allow you to accurately control oxygen in 0.1% increments from 0.1% to 20% and the real time feedback system monitors and adjusts oxygen levels to ensure accuracy. CO2 monitoring is also available. Read More
  • Laboratory Autoclaves

    HypOxygen® carries a complete line of laboratory sterilizers including vertical, bench top, high capacity, and double door autoclave as well as specially designed BSL-3 Autoclaves. Read More
  • CO2 Incubators

    Memmert’s incubators feature a unique sterilization cycle because simply disinfecting the chamber is not reliable. To prevent cross-contamination, the entire incubator chamber, including the ventilation system, shelves/grids can be sterilized with a 4-hour program at 160ºC. Read More
  • TC-3 Cell Culture Bioreactor

    The TC-3 is a simple and multipurpose cell culture bioreactor designed to provide mechanical stimulation to a variety of samples and tissues. Read More
  • All
  • Info
  • Products
  • Default
  • Title
  • Date
  • Random
load more / hold SHIFT key to load all load all

Read what our customers say about their HypOxystations!

Read Testimonials

Hear what others are saying about HypOxystation®

HypOxygen Strengthens Resources

company1

HypOxygen announced on September 8th 2014, that Burga Kalz Fuller, PhD has joined the firm to further enhance their penetration of the HypOxystation hypoxic workstation and related products into the growing field of mammalian cell based hypoxia research.

Burga comes with a wealth of experience within the Life Sciences Industry, having spent the last ten years working with technology suppliers both in Europe and the United States where she was instrumental in the technical supervision of product and equipment development and marketing strategies.

Burga joins HypOxygen as Product Manager to continue HypOxygen's recent success in providing state of the art hypoxic workstations that lead the way in advancing scientific research and innovation.

Burga comments, "I am excited to start a new challenge with HypOxygen and look forward to working with the team. HypOxygen's range of true HEPA hypoxic workstations will play a critical role in furthering advances in the fields of cancer and regenerative medicine research and our HypOxystation has a wealth of special features for ultra-clean, precisely controlled physiological atmosphere that make it truly special. I am fortunate to be joining such a respected company that prides itself on providing industry leading technologies to the growing fields of tissue culture research and hypoxia."

Jason Cadle, National Sales Manager, said "Burga's wealth of molecular cell biology experience and industry knowledge has already made her a key addition to the HypOxygen family. We view her appointment as a sign of our commitment to being the leading company in our industry. Our new innovations and the increasing demand from researchers led us to look for an addition to our team who will fit in with our ethos of innovation and exceptional service. It is very fortunate that we were able to find someone of Burga's caliber to act in this capacity. I'm confident that Burga will play a key role in providing and implementing high quality technical solutions for our clients.”

HypOxystation installed at MD Anderson

mdanderson training

MD Anderson is widely regarded as the best cancer hospital in the United States. Their cancer research center just purchased a HypOxystation H35 for research focused on pancreatic cancer. Dr. Rafal Zielinski had this to say about their new H35 workstation:

The hypoxia station we have purchased is being used for studies on STAT and HIF oncogenic transcription factors in tumors with major focus on pancreatic cancer. It is well established that these tumors are highly hypoxic therefore experiments performed in oxygen-limited conditions better recapitulates the natural environment of the cancer, allows better understanding of the physiologic role of STATs and HIFs and enables more accurate evaluation of experimental therapeutic strategies. We also use chronic hypoxia to study metabolism of the cancer cells and to design optimal therapeutic approaches using new inhibitors of glycolysis.

Keystone Hypoxia Ski Lesson Winners

blog ski1 web

HypOxygen recently attended the Keystone Hypoxia meeting held in Breckenridge, CO. This event focused on advances in understanding the biochemistry and biology of hypoxia signaling and their impact on cell biology, physiology and medicine. HypOxygen participated in a big way, offering demonstrations of the HypOxystation H35, High on Low Oxygen T-shirts and buttons and a private ski lesson giveaway for one lucky winner and his/her lab colleagues!

Congratulations to Alison Janocha and colleagues from the Lerner Research Institute in Cleveland, Ohio. Here are some photographs showing how very much they enjoyed their prize! The Lerner Research Institute is home to all laboratory-based, translational and clinical research at Cleveland Clinic.